LINC02227: A Long Intergenic Non-Protein Coding RNA (G101927697)

Target Name: LINC02227

NCBI ID: G101927697

LINC02227

Other Name(s): long intergenic non-protein coding RNA 2227 | Long intergenic non-protein coding RNA 2227

LINC02227: A Long Intergenic Non-Protein Coding RNA

LINC02227 is a long non-coding RNA (lncRNA) that has been identified in various studies as having potential drug targets or biomarkers. It is a transcribed RNA molecule that is longer than 200 nucleotides and can be expressed in various cell types. LINC02227 is a non-coding RNA molecule that is involved in various cellular processes, including cell adhesion, migration, and survival.

Drug Targets

LINC02227 has been predicted to have several potential drug targets due to its unique structure and various functions. One of the predicted drug targets is the protein known as PDZP2, which is a known regulator of the Wnt signaling pathway. PDZP2 is known to interact with LINC02227 and can activate its expression. This interaction between PDZP2 and LINC02227 suggests that LINC02227 may be a good candidate for drugs that target the Wnt signaling pathway.

Another predicted drug target of LINC02227 is the protein known as CSN3, which is a component of the central nervous system (CNS). LINC02227 has been shown to interact with CSN3 and may play a role in the regulation of the CNS. This interaction between LINC02227 and CSN3 suggests that LINC02227 may be a good candidate for drugs that target the CNS.

Biomarkers

LINC02227 has also been predicted to have potential as a biomarker for various diseases, including cancer and neurodegenerative diseases. One of the potential mechanisms by which LINC02227 may be used as a biomarker is its ability to be expressed in various cell types and its involvement in cellular processes that are relevant to disease.

For example, LINC02227 has been shown to be involved in the regulation of cell adhesion, which is a critical process for the development and maintenance of tissues and organs. This involvement in cell adhesion suggests that LINC02227 may be a good candidate for biomarkers that can be used to diagnose or predict the development of diseases that involve disruptions in cell adhesion, such as cancer.

Another potential use of LINC02227 as a biomarker is its involvement in the regulation of neurodegenerative diseases. LINC02227 has been shown to be involved in the regulation of protein synthesis, which is a critical process for the development and maintenance of neural tissues. This involvement in protein synthesis suggests that LINC02227 may be a good candidate for biomarkers that can be used to diagnose or predict the development of neurodegenerative diseases.

Conclusion

In conclusion, LINC02227 is a long non-coding RNA molecule that has potential as a drug target or biomarker. Its unique structure and involvement in various cellular processes make it an attractive candidate for both drug development and biomarker research. Further studies are needed to determine the full potential of LINC02227 as a drug target or biomarker.

Protein Name: Long Intergenic Non-protein Coding RNA 2227

The "LINC02227 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LINC02227 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets